Judges Scientific plc
("Judges Scientific", "the Company", or "the Group")
Director/PDMR Shareholding
Judges Scientific, a group focused on acquiring and developing companies in the scientific instrument sector , announces that, David Cicurel, Chief Executive Officer, has today sold 50,000 ordinary shares of 5p each in the Company ("Ordinary Shares") at a price of 6,300 pence per Ordinary Share to a number of new and existing institutional shareholders.
The revised beneficial Shareholding for David Cicurel is set out below:
| Shareholding prior to the sale | Ordinary Shares sold | Resultant shareholding | |||
Number | % | Number | % | Number | % | |
David Cicurel* | 709,460 | 11.26 | 50,000 | 0.79% | 659,460 | 10.47 |
* In addition, David has a non-beneficial interest of 50,000 Ordinary Shares.
Ends -
| |
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| David Cicurel | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Executive Officer | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Judges Scientific plc | ||||
b)
| LEI
| 2138004EXWWPTW1JOL31 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares in Judges Scientific plc
GB0032398678
| ||||
b)
| Nature of the transaction
| sale | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
| N/A (single transaction) | ||||
e)
| Date of the transaction
| 19/01/21 | ||||
f)
| Place of the transaction
| London Stock Exchange |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.